Duration Of Treament

-: Duration of treament :- depend on genotype.For genotype 1 Afull year is needed* .for genotype 2 & 3 six monthes are sufficient* some new studies has shown higher success rates When the antiviral drug "Amantadine" is added to interferone & ribavicine. This is called Triple therapy. This may be especially helpful for non – responding patients to interferone & ribavirine .only -:New additions used in treatment of both HB & HC * -:Bile acidsBile acids may improve liver biochemistry of patients with HB* or Hc lout there is insufficient evidence about long term .beneficial effects Bile acids may decrease serum transaminase activities in* patients with acute hepatitis B, chronic hebatitis B or chronic hepatitis C. However, bile acids have no effects in eradicating .viral markers There is insufficient evidence either to support or to refute effects on long term out comes e.g. heap to cellular carcinoma, .decompensated cirrhosis & / or liver related mortality -:( Trans fere factor (TF The results obtained from adult patients receiving TF along * with conventional theraby attests to a high effectiveness of cellular cytokines use in this kind of pathology. Along with normalization of bio chemical values & the decrease of viral load, all patients registered a marked improvement of general state, were more efficient & didn’t experience excessive fatigue .& there was no discomfort in Right hypochondrium ? What is Transfere factor * The colostrum is the milk produced in the(5) few days after child birth. Colostrums contains a potent array of immune factors which can be passed from mother to child & is available in supplement from in health food stores from bovine sources. The principle immune factor in colostrum is a group of molecules called TF It can also be derived from eggyolk protein .& human W.B. C. s -:Post – exposure prophylaxis against H B & Hc

Needle stick injuries &wounds should be washed with soap & water & shouldn’t be squeezed. Mucous membranes should be .flushed with water for HB :- initiation of HB vaccine series with in 12-24h. of an .exposure has been demonstrated .To be 70 – 90 % effective in preventing HBV infection for HC:- people who have HC can get into another infection of one of other genotypes which can make the person sicker so .they should follow general gudelines for protection